Stoke Therapeutics' Zorevunersen Gets FDA Breakthrough Therapy Status in Dravet Syndrome

MT NewswiresDec 4 08:11 ET

Pure Storage Posts Upbeat Results, Joins Cross Country Healthcare, Marvell Technology, Stoke Therapeutics And Other Big Stocks Moving Higher On Wednesday

BenzingaDec 4 10:55 ET

Stoke Therapeutics Shares Rise Premarket on Key FDA Designation

WSJDec 4 07:39 ET

Express News | Stoke Therapeutics Inc - Phase 3 Registration Study Update Expected by Year-End

ReutersDec 4 07:00 ET

Express News | Stoke Therapeutics Receives FDA Breakthrough Therapy Designation for Zorevunersen for the Treatment of Dravet Syndrome

ReutersDec 4 07:00 ET

Insider Sale: CHIEF MEDICAL OFFICER of $STOK (STOK) Sells 10,000 Shares

Quiver QuantitativeDec 3 16:18 ET